LAB
Standard Biotools Inc.Company with tickers: LAB
Market Cap
$293.72M
Shares Outstanding
390,071,506
CIK
1162194
CUSIP
34385P108
13F Activity (30d)
4 filings
3 filers
Website
Visit website
Investor Relations
Investor relations
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Eli Casdin | Class I director | Appointed | 2026-06-18 |
| Thomas Carey | Class I director | Appointed | 2026-06-18 |
| Michael Egholm, Ph.D. | Class I director | Appointed | 2026-06-18 |